BULL stock has lost about 91% of its value from its 52-week high of $79.56. ・On Jan. 27, Webull announced that it has ...

OCALA, Fla., Feb. 06, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today that it will participate in the Corporate Connect Webinar Series hosted by ...

Webull Corporation (NASDAQ:BULL) shares are trading higher Thursday after the company announced it will reintroduce crypto trading to its global customer base and integrate Webull Pay back into Webull ...

Alice Hoekstra is a former Content Strategist for Motley Fool Money, where she worked full-time for almost five years. Alice worked on content across a wide range of financial topics, including credit ...

Rosenblatt Securities has issued a buy rating on Webull (NASDAQ: BULL), arguing that its 28% drop over the last three months presents a buying opportunity before the company reports its Q4 earnings.

In late January 2026, Webull Financial LLC highlighted its expanding partnership with CFTC-regulated Kalshi, offering users sports and Big Game prediction markets with $0 commission on select event ...

A full comparison of Robinhood and Webull in 2026. Evaluate asset selection, fees, user interfaces, and more to find the best ...

Webull Corp (NASDAQ:BULL) shares are trading lower by 7.37% to $12.51 during Friday’s session, reacting to the release of the company’s first-quarter financial results late Thursday. What To Know: The ...

Transfer RM10,000 or more in shares to receive 2% Match Rewards, with up to RM100,000 in Nvidia shares up for grabs!​ ...

These days you don’t have to pay a penny in commissions to trade stocks or ETFs or fork over a dime to access investment research and portfolio management tools. It’s the perks that’ll cost you extra.

Akari Therapeutics, Plc (Nasdaq: AKTX ), an oncology biotechnology company pioneering next-generation antibody drug ...

Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), a preclinical biopharmaceutical that is engineering the next generation of peptide conjugate therapeutics, today announced that it will ...